Publicaciones
-
Atkinson JM, Shelat AA, Carcaboso AM, Kranenburg TA, Arnold LA, Boulos N, Wright K, Johnson RA, Poppleton H, Mohankumar KM, Féau C, Phoenix T, Gibson P, Zhu L, Tong Y, Eden C, Ellison DW, Priebe W, Koul D, Yung WK, Gajjar A, Stewart CF, Guy RK and Gilbertson RJ.
An Integrated In Vitro and In Vivo High-Throughput Screen Identifies Treatment Leads for Ependymoma
Cancer Cell . 20(3): 384-399. Nº de citas: 94
-
Nemeth KM, Federico S, Carcaboso AM, Shen Y, Schaiquevich P, Zhang J, Egorin M, Stewart C and Dyer MA.
Subconjunctival Carboplatin and Systemic Topotecan Treatment in Preclinical Models of Retinoblastoma
CANCER . 117(2): 421-434. Nº de citas: 44
-
Elmeliegy MA, Carcaboso AM, Tagen M, Bai F and Stewart CF.
Role of ATP-Binding Cassette and Solute Carrier Transporters in Erlotinib CNS Penetration and Intracellular Accumulation
CLINICAL CANCER RESEARCH . 17(1): 89-99. Nº de citas: 97
-
Carcaboso AM, Elmeliegy MA, Shen J, Juel SJ, Zhang ZM, Calabrese C, Tracey L, Waters CM and Stewart CF.
Tyrosine Kinase Inhibitor Gefitinib Enhances Topotecan Penetration of Gliomas
CANCER RESEARCH . 70(11): 4499-4508. Nº de citas: 72
-
Carcaboso AM, Chiappetta DA, Opezzo JA, Höcht C, Fandiño AC, Croxatto JO, Rubio MC, Sosnik A, Abramson DH, Bramuglia GF and Chantada G.
Episcleral Implants for Topotecan Delivery to the Posterior Segment of the Eye
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE . 51(4): 2126-2134. Nº de citas: 42
-
Sosnik A, Carcaboso AM, Glisoni RJ, Moretton MA and Chiappetta DA.
New old challenges in tuberculosis: Potentially effective nanotechnologies in drug delivery
ADVANCED DRUG DELIVERY REVIEWS . 62(4-5): 547-559. Nº de citas: 228
-
Blake MG, Boccia MM, Carcaboso AM, Chiappetta DA, Höcht C, Krawczyk MC, Sosnik A and Baratti CM.
Novel long-term anticonvulsant treatment with gabapentin without causing memory impairment in mice
EPILEPSY & BEHAVIOR . 17(2): 157-164. Nº de citas: 3
-
Chantada G, Fandino AC, Carcaboso AM, Lagomarsino E, de Davila MT, Guitter MR, Rose AB, Manzitti J, Bramuglia GF and Abramson DH.
A Phase I Study of Periocular Topotecan in Children with Intraocular Retinoblastoma
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE . 50(4): 1492-1496. Nº de citas: 28
-
Liu I, Alencastro Veiga Cruzeiro G, Bjerke L, Rogers RF, Grabovska Y, Beck A, Mackay A, Barron T, Hack OA, Quezada MA, Molinari V, Shaw ML, Perez-Somarriba M, Temelso S, Raynaud F, Ruddle R, Panditharatna E, Englinger B, Mire HM, Jiang L, Nascimento A, LaBelle J, Haase R, Rozowsky J, Neyazi S, Baumgartner AC, Castellani S, Hoffman SE, Cameron A, Morrow M, Nguyen QD, Pericoli G, Madlener S, Mayr L, Dorfer C, Geyeregger R, Rota C, Ricken G, Ligon KL, Alexandrescu S, Cartaxo RT, Lau B, Uphadhyaya S, Koschmann C, Braun E, Danan-Gotthold M, Hu L, Siletti K, Sundström E, Hodge R, Lein E, Agnihotri S, Eisenstat DD, Stapleton S, King A, Bleil C, Mastronuzzi A, Cole KA, Waanders AJ, Carcaboso AM, Schüller U, Hargrave D, Vinci M, Carceller F, Haberler C, Slavc I, Linnarsson S, Gojo J, Monje M, Jones C and Filbin MG.
GABAergic neuronal lineage development determines clinically actionable targets in diffuse hemispheric glioma, H3G34-mutant.
Cancer Cell . : . Nº de citas: 1